Lisa Bollinger - 05 Jun 2024 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APGE	Stock Option (Right to Buy)	Award	$0	+8,112		$0.000000	8,112	05 Jun 2024	Common Stock	8,112	$43.85	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option represents the right to purchase 8,112 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.